Andus, T; Palmqvist, A; Arends, J et al.
New German S3-Guideline 'Diagnosis and Treatment of Esophagogastric Cancer'VISZERALMEDIZIN. Bd. 28. H. 2. 2012 S. 129-132
Boehm, N; Wolters, D; Thiel, U et al.
New insights into autoantibody profiles from immune privileged sites in the eye: A glaucoma studyBRAIN BEHAVIOR AND IMMUNITY. Bd. 26. H. 1. 2012 S. 96-102
Hollemann, David; Yanagida, Genya; Rueger, Beate M. et al.
New vessel formation in peritumoral area of squamous cell carcinoma of the head and neckHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. Bd. 34. H. 6. 2012 S. 813-820
Reclaru, L.; Unger, R. E.; Kirkpatrick, C. J. et al.
Ni-Cr based dental alloys; Ni release, corrosion and biological evaluationMATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS. Bd. 32. H. 6. 2012 S. 1452-1460
Mobascher, Arian; Warbrick, Tracy; Brinkmeyer, Juergen et al.
Nicotine effects on anterior cingulate cortex in schizophrenia and healthy smokers as revealed by EEG-informed fMRIPSYCHIATRY RESEARCH-NEUROIMAGING. Bd. 204. H. 2-3. 2012 S. 168-177
Warbrick, T; Mobascher, A; Brinkmeyer, J et al.
Nicotine Effects on Brain Function during a Visual Oddball Task: A Comparison between Conventional and EEG-informed fMRI AnalysisJOURNAL OF COGNITIVE NEUROSCIENCE. Bd. 24. H. 8. 2012 S. 1682-1694
Luckhaus, C; Henning, U; Ferrea, S et al.
Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [H-3]-nicotine binding is decreased in schizophrenia and correlates with negative symptomsJOURNAL OF NEURAL TRANSMISSION. Bd. 119. H. 5. 2012 S. 587-595
Mengel, E; Beck, M; Das, AM et al.
Niemann-Pick disease type C. Clinical symptoms, diagnostics and therapyMONATSSCHRIFT KINDERHEILKUNDE. Bd. 160. H. 1. 2012 S. 47-+
Heinrich, UR; Helling, K
Nitric oxide - A versatile key player in cochlear function and hearing disordersNITRIC OXIDE-BIOLOGY AND CHEMISTRY. Bd. 27. H. 2. 2012 S. 106-116
Knorr, M; Steven, S; Hausding, M et al.
Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase - Beneficial effects of therapy with the AT(1)-receptor blocker telmisartanVASCULAR PHARMACOLOGY. Bd. 56. H. 5-6. 2012 S. 351-352